Evidence map›Paper›PMID 41889872›Full record

ArticlebioRxiv : the preprint server for biology2026

Non-canonical peptidoglycan cross-linking is essential for

Ruoyao Ma, Daniel Rea, Karl Ocius, Ananya Naick, Claire Healy, Thomas R Ioerger, Marcos Pires, Felipe Cava, Alexandre Gouzy, Sabine Ehrt

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ruoyao MaDepartment of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States.ORCID 0000-0002-8203-9421
Daniel ReaDepartment of Molecular Biology, Umeå University, Umeå, SE-901 87, Sweden.ORCID 0009-0009-6904-1031
Karl OciusDepartment of Microbiology, Immunology, and Cancer, University of Virginia, Charlottesville, Virginia 22904, United States.ORCID 0009-0008-0578-8964
Ananya NaickDepartment of Microbiology, Immunology, and Cancer, University of Virginia, Charlottesville, Virginia 22904, United States.ORCID 0009-0005-5669-4317
Claire HealySchool of Medicine, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0001-6903-2455
Thomas R IoergerDepartment of Computer Science and Engineering, Texas A&M University, College Station, Texas, United States.ORCID 0000-0001-8702-9102
Marcos PiresDepartment of Microbiology, Immunology, and Cancer, University of Virginia, Charlottesville, Virginia 22904, United States.ORCID 0000-0002-5676-0725
Felipe CavaDepartment of Molecular Biology, Umeå University, Umeå, SE-901 87, Sweden.ORCID 0000-0001-5995-718X
Alexandre GouzyDepartment of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States.ORCID 0000-0001-6671-7408
Sabine EhrtDepartment of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States.ORCID 0000-0002-7951-2310

Funding

Surviving evolution: Short-term adaptations for fitnessP01AI143575 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SABINE EHRT · 2020 to 2026
$18.2M
Unraveling Bacterial Cell Wall Biosynthesis and Sensing via Synthetic AnalogsR35GM124893 · NIGMS · UNIVERSITY OF VIRGINIA · PI Marcos M. Pires · 2017 to 2026
$3.6M
NIAID NIH HHS P01 AI143575NIGMS NIH HHS R35 GM124893
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41889872
PMCPMC13015542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.